SCHEMBL3299147

SCHEMBL3299147

CC(=O)OC(c1ccccc1)[N+](=O)[O-]

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
CYP3A4 P08684 1/20 0.49
GSR P00390 1/20 0.41
PABPC1 P11940 1/20 0.39
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 1/20 0.39
HSD17B10 Q99714 1/20 0.38
FBP1 P09467 1/20 0.37
HPGD P15428 1/20 0.37
PTGS2 P35354 1/20 0.37
HCAR2 Q8TDS4 1/20 0.37
CYP2D6 P10635 1/20 0.36
SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL286963 0.85 GSR (0.43) ALDH1A1CYP3A4GSRKMT2ACYP2D6
SCHEMBL22323630 0.85 GSR (0.43) ALDH1A1CYP3A4GSRKMT2AMEN1
SCHEMBL27847496 0.84 KMT2A (0.46) ALDH1A1CYP3A4GSRTSHRKMT2A
SCHEMBL5932816 0.84 GSR (0.42) ALDH1A1CYP3A4GSRKMT2ACYP2D6
SCHEMBL2208139 0.83 HPGD (0.40) ALDH1A1CYP3A4GSRKMT2AMEN1
Methyl Alcohol SCHEMBL9278113 0.83 NPSR1 (0.41) ALDH1A1CYP3A4GSRKMT2ACYP2D6
SCHEMBL258789 0.82 GSR (0.41) ALDH1A1CYP3A4GSRTSHRKMT2A
SCHEMBL38107 0.82 NPSR1 (0.43) ALDH1A1GSRCYP2D6SRC
SCHEMBL10640253 0.82 GSR (0.41) ALDH1A1CYP3A4GSRKMT2ACYP2D6
SCHEMBL5932183 0.82 GSR (0.41) ALDH1A1CYP3A4GSRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737283-B2 Anti-inflammatory medicaments DECIPHERA PHARMACEUTICALS, LLC (US) 2010-06-15 US disclosed
US-20090312349-A1 ANTI-INFLAMMATORY MEDICAMENTS DECIPHERA PHARMACEUTICALS, LLC 2009-12-17 US disclosed
EP-1836173-A4 ANTI-INFLAMMATORY MEDICAMENTS DECIPHERA PHARMACEUTICALS LLC (US) 2009-07-08 EP disclosed
US-7531566-B2 Anti-inflammatory medicaments DECIPHERA PHARMACEUTICALS, LLC (US) 2009-05-12 US disclosed
US-20090105230-A1 Anti-inflammatory medicaments FLYNN DANIEL L 2009-04-23 US disclosed
US-20090075986-A1 Anti-inflammatory medicaments DECIPHERA PHARMACEUTICALS, LLC 2009-03-19 US disclosed
US-20080187978-A1 Anti-inflammatory medicaments FLYNN DANIEL L 2008-08-07 US disclosed
US-20080132506-A1 Anti-inflammatory medicaments FLYNN DANIEL L 2008-06-05 US disclosed
US-20080064688-A1 Anti-inflammatory medicaments DECIPHERA PHARMACEUTICALS, LLC 2008-03-13 US disclosed
US-7342037-B2 Anti-inflammatory medicaments DECIPHERA PHARMACEUTICALS, LLC (US) 2008-03-11 US disclosed
US-20050287469-A1 Photosensitive composition for interlayer dielectric and method of forming patterned interlayer dielectric NAGAHARA TATSURO 2005-12-29 US disclosed
CN-1675590-A Photosensitive composition for interlayer dielectric and method of forming patterned interlayer dielectric AZ ELECTRONIC MATERIALS JAPAN (JP) 2005-09-28 CN disclosed
EP-1560069-A1 PHOTOSENSITIVE COMPOSITION FOR INTERLAYER DIELECTRIC AND METHOD OF FORMING PATTERNED INTERLAYER DIELECTRIC AZ Electronic Materials (Japan) K.K. (JP) 2005-08-03 EP disclosed
EP-1548499-A1 PHOTOSENSITIVE COMPOSITION FOR INTERLAYER DIELECTRIC AND METHOD OF FORMING PATTERNED INTERLAYER DIELECTRIC AZ Electronic Materials (Japan) K.K. (JP) 2005-06-29 EP disclosed
US-6902875-B2 Photosensitive polysilazane composition, method of forming pattern therefrom, and method of burning coating film thereof CLARIANT FINANCE (BVI) LIMITED (VG) 2005-06-07 US disclosed
US-20040081912-A1 Photosensitive polysilazane composition and method of forming patterned polysilazane film AZ ELECTRONIC MATERIALS USA CORP. 2004-04-29 US disclosed
US-20030113657-A1 Photosensitive ploysilazane composition, method of forming pattern therefrom, and method of burning coating film thereof MERCK PATENT GMBH (DE) 2003-06-19 US disclosed
CN-1381756-A Adhesive sheet, layered sheet and liquid crystal display unit SHARP KK (JP) 2002-11-27 CN disclosed
EP-1239332-A1 PHOTOSENSITIVE POLYSILAZANE COMPOSITION, METHOD OF FORMING PATTERN THEREFROM, AND METHOD OF BURNING COATING FILM THEREOF CLARIANT INTERNATIONAL LTD. (CH) 2002-09-11 EP disclosed
EP-1164435-A1 PHOTOSENSITIVE POLYSILAZANE COMPOSITION AND METHOD OF FORMING PATTERNED POLYSILAZANE FILM TonenGeneral Sekiyu K.K. (JP) 2001-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064688-A1 Anti-inflammatory medicaments MIF, PTGES2, TNF ALDH1A1 3257/4885CYP3A4 4423/4885GSR 2349/4885
US-20090105230-A1 Anti-inflammatory medicaments MIF, PTGES2, TNF ALDH1A1 3257/4885CYP3A4 4423/4885GSR 2349/4885
US-20090075986-A1 Anti-inflammatory medicaments MIF, PTGES2, TNF ALDH1A1 3257/4885CYP3A4 4423/4885GSR 2349/4885
US-20090312349-A1 ANTI-INFLAMMATORY MEDICAMENTS ABL2, ABL1, PTK2 ALDH1A1 1756/4885CYP3A4 4388/4885GSR 2767/4885
US-20080132506-A1 Anti-inflammatory medicaments MIF, PTGES2, TNF ALDH1A1 3257/4885CYP3A4 4423/4885GSR 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.